FDA Approves DEXTROSE — Baxter Healthcare Corporation

Baxter Healthcare Corporation’s continued FDA validation of its Dextrose Monohydrate product reinforces the manufacturer’s dominant position in the intravenous nutrition market, ensuring reliable revenue streams from this essential medical supply.